Literature DB >> 21609934

Long-term outcome of early-stage rectal cancer undergoing standard resection and local excision.

Junjie Peng1, Wei Chen, Alan P Venook, Weiqi Sheng, Ye Xu, Zuqing Guan, Guoxiang Cai, Sanjun Cai.   

Abstract

OBJECTIVES: To explore the long-term outcome and prognostic factors for early stage rectal cancer patients undergoing standard resection (SR) or local excision (LE). PATIENTS AND METHODS: This study included 350 patients with stage I rectal cancer, in which 283 cases (80.9%) received SR, and 67 cases (19.1%) received LE. Survival analyses were performed to compare outcomes of different surgeries.
RESULTS: The 5-year local recurrence (LR) rate was 14.1% in LE group versus 3.3% in SR group (P= .0004), and the 10-year overall survival (OS) rate was not significantly different between the 2 groups. Multivariate analysis suggested that LE was an independent risk factor for 5-year LR rate and 10-year OS rate. Tumor grade was found related to 5-year LR, and T stage was found related to 10-year OS. Tumor size of 2.5 cm is found as a possible cut-off for predicting 5-year LR rate in LE group, with a sensitivity of 77.8% and a specificity of 75.9%. In patients with LE, the 5-year LR rate for tumors ≥ 2.5 cm was 40%, compared with 4.3% for tumors < 2.5 cm (P = .001).
CONCLUSION: Local excision in early-stage rectal cancer may result in high local recurrence rate. The procedure is only recommended in highly selective groups of patients. A tumor size of 2.5 cm is a useful criterion for choosing LE rather than SR.

Entities:  

Mesh:

Year:  2011        PMID: 21609934     DOI: 10.3816/CCC.2011.n.005

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  8 in total

Review 1.  Local Excision and Endoscopic Resections for Early Rectal Cancer.

Authors:  Guilherme Pagin São Julião; Juan Pablo Celentano; Flavia Andrea Alexandre; Bruna Borba Vailati
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

2.  Analysis of local recurrences after transanal endoscopic microsurgery for low risk rectal carcinoma.

Authors:  Theodor Junginger; Ursula Goenner; Mirjam Hitzler; Tong T Trinh; Achim Heintz; Wilfried Roth; Maria Blettner; Daniel Wollschlaeger
Journal:  Int J Colorectal Dis       Date:  2016-11-25       Impact factor: 2.571

3.  Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies.

Authors:  Alice Dewdney; David Cunningham; Ian Chau
Journal:  Oncologist       Date:  2013-07-02

Review 4.  Toward the non-surgical management of locally advanced rectal cancer.

Authors:  Alice Dewdney; David Cunningham
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

5.  A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma.

Authors:  Michelle Olsheski; David Schwartz; Justin Rineer; Angela Wortham; Sonal Sura; Gainosuke Sugiyama; Marvin Rotman; David Schreiber
Journal:  J Gastrointest Cancer       Date:  2013-09

6.  Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?

Authors:  Junjie Peng; Xinxiang Li; Ying Ding; Debing Shi; Hongbin Wu; Sanjun Cai
Journal:  Radiat Oncol       Date:  2013-12-19       Impact factor: 3.481

7.  Initial local excision for clinical T1 rectal cancer showed comparable overall survival despite high local recurrence rate: a propensity-matched analysis.

Authors:  Jong Hee Hyun; Mohamed K Alhanafy; Hyoung-Chul Park; Su Min Park; Sung-Chan Park; Dae Kyung Sohn; Duck-Woo Kim; Sung-Bum Kang; Seung-Yong Jeong; Kyu Joo Park; Jae Hwan Oh
Journal:  Ann Coloproctol       Date:  2021-10-06

8.  Approach to rectal cancer surgery.

Authors:  Terence C Chua; Chanel H Chong; Winston Liauw; David L Morris
Journal:  Int J Surg Oncol       Date:  2012-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.